Preview

Write Up on the India Pharma Industry

Satisfactory Essays
Open Document
Open Document
973 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Write Up on the India Pharma Industry
Write up on The Indian Pharmaceutical Industry using Competitive Structure of Industry Models.
Key Characteristics of Indian Pharmaceutical Industry: * Highly Regulated: The industry faces Price, Quality & Patent regulation. * Research Oriented: Highly research driven, regularly invents NDDS (Novel Drug Delivery System) along with new molecules & innovative production process. * Low Price Elasticity: Consumers less sensitive to price movements for most drugs * Limited Customer Choice: Consumers are not decision makers, Doctors & Medical Representatives play major role. * Highly Dependent on The Development of Health Infrastructure: Hospitals, health facilities, medical practitioners plays a key role in driving consumption. * Estimated $700 bn. in 2007. * Growth rate 6% in CAGR. * Expected to reach $937 bn. in 2012.
Key Issues of Indian Pharmaceutical Industry:
The Indian pharmaceutical industry is estimated to have over 10,000 manufacturing units, as given by the Organisation of Pharmaceutical Producers of India. ORGANISED SECTOR | UNORGANISED SECTOR | 5% of the industry | 95% of the industry | 65% of industry turnover | 35% of industry turnover | 19% turnover from MNC.81% turnover from Indian Companies. | |

Price Erosion in Indian Generics is due to: * Price control imposed by government * Rise in number of domestic players
National List of Essential Medicines - (NLEM) lists 354 Drugs under cost based price control by National Pharmaceutical Policy 2006. The field of discovery and developments of New Chemical Entity (NCEs) had more misses than hits. Very few discoveries reach the final stages of approvals, and in most of the cases the claim for patent gets stuck in legal battles. Indian Companies spend 4% of Sales on R&D, where the Global practice is of 12-16%. Leading Indian Pharmaceutical companies have been actively extending the frontiers of scientific knowledge & going global

You May Also Find These Documents Helpful

  • Powerful Essays

    Ambulatory Care

    • 11796 Words
    • 48 Pages

    118 • CHAPTER 6 Ferreter, M. (2000). Taking their cut. Modern Physician, 4(1), 40. Greenfield, S., Nelson, E., Zubkoff, M., Manning, W., Rogers, W., Kravitz, R., Keller, A., Tarlov, A., & Ware, J. (1992, March 25). Variations in resource utilization among medical specialties and systems of care. JAMA, 269(12), 1624–1630. Hall, M., & Lawrence, L. (1998). Advance data: Ambulatory surgery in the United States, 1996 (Vital and Health Statistics, Vol. 300). Hyattsville, Maryland: National Center for Health Statistics. Health Care Financing Administration. (1998, July 23). CLIA: General program description [On-line]. Available: www.hcfa.gov/medicaid/clia/ progdesc.htm (Accessed April 24, 2000). Henderson, J. (1992, May 18). Surgicenters cut further into market. Modern Healthcare, pp. 108–110. MacColl, W. A. (1966). Group practice and prepayment of medical care. Washington, DC: Public Affairs Press. Medical World News. (1973, September 21). Moran, M. (1998, March 9). More physicians are employees. American Medical News, pp. 7–8. Moskowitz, D. (1999). 1999 health care almanac & yearbook. New York: Faulkner & Gray. Patient dumping: Hospitals caught between feds, HMOs. (1999, February 19) American Health Line. Starr, P. (1982). The social transformation of American medicine. New York: Basic Books. U.S. Department of Health, Education, and Welfare. (1970). Medical care for the American people: Final report of the Committee on the Costs of Medical Care. Chicago: University of Chicago Press. Woodwell, D. (1999). National ambulatory medical care survey: 1997 summary. Hyattsville, MD: National Center for Health Statistics.…

    • 11796 Words
    • 48 Pages
    Powerful Essays
  • Best Essays

    Allied Health Care Products

    • 4278 Words
    • 18 Pages

    While the current quality or condition to change in healthcare as a private benefit is preserved, in the last three markets, market failures result in the financing and delivery markets because accurate information about product price is not a pragmatic conjecture—and various limits of access exist in the financing markets; such as the monopolistic structure of the health insurance industry.…

    • 4278 Words
    • 18 Pages
    Best Essays
  • Good Essays

    The Pharmaceutical industry has several high entry barriers as shown in figure 1. Economies of scale, product differentiation, government policy and capital requirements and financial services are few barriers for new entrant. Level of threat from rivalry is also high in this industry. Industry has presence of large number of small firms of a similar size. They are in direct competition with one another,…

    • 1056 Words
    • 5 Pages
    Good Essays
  • Powerful Essays

    Merck Business Analysis

    • 1943 Words
    • 8 Pages

    The global pharmaceutical market is likely to undergo a wide variety of changes with new competition arising in India, China, Malaysia, South Korea, and Indonesia. This new competition has a growing economy and has made a difference between the product cost and disposable income of consumers. According to NASDAQ (2011),“ Global pharmaceutical market sales are expected to grow at a 4-7% through the year 2013 largely being driven by the growing access to health care in emerging economic regions” (para. 2-5). Short-term growth within this area is stimulated by the United States market, as it continues to be the largest pharmaceutical market in the world. A focal point on research and development in special drugs and generic drugs will remain a strong means to meet 2011 goals of earning $315 billion dollar in sales within the United States.…

    • 1943 Words
    • 8 Pages
    Powerful Essays
  • Powerful Essays

    then suggest the switch to a patient 's doctor. This prospect of increasing sales is enormous. second, the…

    • 2327 Words
    • 10 Pages
    Powerful Essays
  • Powerful Essays

    Ego Executive Report

    • 3226 Words
    • 13 Pages

    Greene, W. (2007), “The emergence of India’s pharmaceutical industry and implications for the US Generic Drug Market”, US International Trade Commission.…

    • 3226 Words
    • 13 Pages
    Powerful Essays
  • Good Essays

    There are number of factors that have contributed towards this phenomenal growth in the drug industry. The initial event that initiated the growth was India’s agreement with WTO which gave protection to intellectual property rights and assurance to international investors. Also, there are several internal factors within India which have successfully contributed to the growth of the industry. Similar to China, India has comparative advantage in manufacturing and packaging which encouraged Western companies to outsource in India. The comparative advantage has been gained due to abundance of educated work force, low wage rates and the wide spread use of English as a business language. This latter factor, the wide use of English language is one of the main reasons why Western companies chose India over China. For foreign investors, it is much easier to conduct business…

    • 860 Words
    • 4 Pages
    Good Essays
  • Good Essays

    The Pharmaceutical Industry: Key success factors High profit after launching the product: Before a pharmaceutical company establishes a new product it takes them a lot time and work. The whole project, from the beginning until the end, where the medicine can be launched can last about 12 years. But once the drug is on marked the producing company has very high margins. On average, a Blockbuster drug is for about eight years on the marked and each year it has revenues in the range of one billion US$. That means, that the producing company has with one Blockbuster drug in eight years about eight billion US$. High demand: There is not only a demand for all kind of drugs, there is a strong need for some of them. Another very important reason is the fact, that in some countries, the healthy system is passed into private hands. That turns the medical health care to a luxury good. People with less money, stay in the normal public insurance system. Those who have a higher income can change to the private health care system. If you are in this private system, doctors prescribe very expensive drugs and provide you with a better service, because they make more money with it. (Example from Germany) Demographic reasons: Strict legalizations Before you bring a drug on the marked, it has to be legal approved by government organizations. But before the drugs can be approved companies have to start developing. That takes them a lot time and over all a high amount of money before they know, that there product will be really approved. The research and development costs in this industry are very high. The fact that companies have to invest such a high amount of money is a big risk for them. Those companies that have already established some successful drugs have advantages against smaller companies. You need money and time, which smaller and new companies probably not always have. So once you are an established and successful company in this…

    • 610 Words
    • 3 Pages
    Good Essays
  • Powerful Essays

    • • • • • • • History Indian Pharmaceutical Evolution Facts and Figures Regulatory Framework Current ongoing activities SWOT Analysis The India Advantage…

    • 1400 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    The Indian Pharmaceutical Industry is among top five producers of bulk drugs in the world. Pharmaceuticals market can be roughly classified into Bulk drugs (20% of the market) registering growth rates of 20% and formulations (80% of the market) with an annual growth rate of 15%.There are about 8174 bulk drug manufacturing units and 2389 formulations units spread across the country.…

    • 11559 Words
    • 47 Pages
    Powerful Essays
  • Best Essays

    Analysis of Business Model

    • 4198 Words
    • 17 Pages

    14. Greene, W., 2007. The emergence of India 's pharamceutical industry and implications for the U.S. generic drug market. Office of economic, Volume 2007-05-A.…

    • 4198 Words
    • 17 Pages
    Best Essays
  • Powerful Essays

    Indian Healthcare Industry

    • 15925 Words
    • 64 Pages

    – – Indian Healthcare Industry Market Segments Industry overview Porter‘s Five Forces Analysis Growth Drivers Operating Business Models Innovative Delivery Formats Growth strategies in the Industry Key Trends Opportunities Challenges Government Initiatives…

    • 15925 Words
    • 64 Pages
    Powerful Essays
  • Powerful Essays

    Judicial System in India

    • 9080 Words
    • 45 Pages

    There has been a large growth in the Pharmaceutical industry in the world and as well as in India in the recent years.…

    • 9080 Words
    • 45 Pages
    Powerful Essays
  • Good Essays

    PESTLE Analysis of the Pharmaceutical Industry Political - Recent US health reforms has led to increased pressure on price. - Increased push for continued overseas aid, particularly through the United Nations and the European Union, with price of the drugs being a major factor in the supplier choice. Economical - Due to the current economic climate, price has become a major factor in pharmaceuticals especially on drugs where generic brands are also available. Social - Skilled employees can be difficult to source in other third world countries where segments of the batch production line may be based. - Increasing pressure on pharmaceutical industry to support developing countries through the supply of reduced cost drugs, tightening margins. Technological - Technology evolution in the industry is fast and needs to be updated frequently to avoid being left behind with the first to implement radical new technology into the production process gaining 'first mover' advantages Legal - Many legal restraints to releasing drugs suitable for human consumption - High legal costs associated with passing drugs for human consumption and dealing with unforeseen side effects of a drug Environmental - Batch production processes of pharmaceutical products can have manufacturing plants based in multiple countries. The carbon footprint of many drugs can be very large due to the amount of transport involved in the batch production processes.…

    • 3196 Words
    • 13 Pages
    Good Essays
  • Good Essays

    Eli Lilly Case

    • 3871 Words
    • 16 Pages

    Global pharmaceuticals had presence in India since early 80’s and it was not until 1993 that Eli Lilly International decided to establish a Joint Venture with India’s second largest laboratory and exporter, Ranbaxy. This move happened in a very challenging context as both companies have very different profiles and backgrounds. The main differential characteristic was the nature of their products. While Ranbaxy was focused on generics and in other intermediate products, Eli Lilly International core business was the commercialization and development of new drugs through an aggressive R&D strategy. The trigger for Eli Lilly to start thinking of going into India was the liberalization process in pharmaceutical markets as a consequence of the change of the economic model from import-substitution to an export-oriented. The foreign ownership was allowed to be 51% (rose from 30%) and additional free market conditions were expected for the coming years. Despite this trend, there were many restrictions that Eli Lilly would have faced if they did not count with a local partner. These include access to government pharmaceutical and health relevant authorities, an adequate logistics and distribution system, and manufacturing facilities. For Ranbaxy, the main objective was to gain additional market share and increase in sales. The Joint Venture was established, and worked through the years with good results. Ranbaxy (including Eli Lilly) went from the 3rd place in market share in 1996, to the first place in year 2000.…

    • 3871 Words
    • 16 Pages
    Good Essays